Skip to content

Clinical trials

Lymphoma, Large B-Cell, Diffuse trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Unknown status Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20023
20031
20053
20065
20074
20083
20093
20106
20114
20126
20136
20141
201511
201629
201714
20188
201917
202016
202113
202218
202320
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status216

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital18
The First Affiliated Hospital with Nanjing Medical University9
Fudan University7
Asan Medical Center4
Chinese PLA General Hospital4
Fondazione Italiana Linfomi - ETS4
Jonsson Comprehensive Cancer Center4
Nanfang Hospital, Southern Medical University4
PersonGen BioTherapeutics (Suzhou) Co., Ltd.4
Sun Yat-sen University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse216
Lymphoma, Follicular52
Lymphoma, Mantle-Cell46
Lymphoma43
Lymphoma, Non-Hodgkin43
Leukemia, Lymphocytic, Chronic, B-Cell40
Burkitt Lymphoma32
Precursor Cell Lymphoblastic Leukemia-Lymphoma32
Lymphoma, Large-Cell, Immunoblastic31
Lymphoma, B-Cell, Marginal Zone28

Trials

Showing 1 to 25 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.